Delisting risk
YCBD · AMEX · Drug Manufacturers - Specialty & Generic

cbdMD

Develops cannabinoid wellness, pet CBD, mushroom supplements, and THC beverages.

$0.5000
After-hours close−0.01 (−1.90%)
At close$0.5097(+2.53%)
DateEstimateReportedSurprise
Aug 2026−$0.03−$0.11−266.7%
May 2026−$0.05−$0.08−60.0%
Feb 2026−$0.06−$0.04+33.3%
Dec 2025−$0.07−$0.08−8.9%

The latest year is open to everyone — the 37 quarters behind it read with an account.

Sign in
Aug 2025
May 2025
Feb 2025
Dec 2024
Aug 2024
May 2024
Feb 2024
Jan 2024
Aug 2023
May 2023
Feb 2023
Dec 2022
Aug 2022
May 2022
Feb 2022
Dec 2021
Aug 2021
May 2021
Feb 2021
Dec 2020
Aug 2020
May 2020
Feb 2020
Dec 2019
Aug 2019
May 2019
Feb 2019
Dec 2018
Aug 2018
May 2018
Feb 2018
Dec 2017
Jun 2017
Mar 2017
Dec 2016
Sep 2016
Jun 2016
Report dateEPS estEPSSurpriseRevenue estRevenueSurprise
Aug 13, 2026−$0.03−$0.11−266.7%$5.7M$5.6M−2.4%
May 14, 2026−$0.05−$0.08−60.0%$5.3M$5.6M+6.6%
Feb 17, 2026−$0.06−$0.04+33.3%$4.9M$5.0M+3.3%
Dec 19, 2025−$0.07−$0.08−8.9%$4.7M$4.7M+0.4%

The latest year is open to everyone — the 37 quarters behind it read with an account.

Sign in
Aug 14, 2025
May 15, 2025
Feb 13, 2025
Dec 27, 2024
Aug 14, 2024
May 15, 2024
Feb 13, 2024
Jan 29, 2024
Aug 10, 2023
May 15, 2023
Feb 13, 2023
Dec 15, 2022
Aug 11, 2022
May 13, 2022
Feb 10, 2022
Dec 17, 2021
Aug 12, 2021
May 12, 2021
Feb 9, 2021
Dec 22, 2020
Aug 12, 2020
May 18, 2020
Feb 13, 2020
Dec 18, 2019
Aug 14, 2019
May 15, 2019
Feb 14, 2019
Dec 12, 2018
Aug 14, 2018
May 15, 2018
Feb 14, 2018
Dec 26, 2017
Jun 30, 2017
Mar 31, 2017
Dec 31, 2016
Sep 30, 2016
Jun 30, 2016